Evidence map›Paper›PMID 25365551›Full record

Trial reportEye & contact lens2014

Effects of corneal cross-linking on ocular response analyzer waveform-derived variables in keratoconus and postrefractive surgery ectasia.

Katie M Hallahan, Karolinne Rocha, Abhijit S Roy, J Bradley Randleman, R Doyle Stulting, William J Dupps

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Eye & contact lens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Corneal collagen cross-linking for treating keratoconus.The Cochrane database of systematic reviews · 2015
    Pooled it
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Biomechanical Diagnostics of the Cornea.International ophthalmology clinics · 2017
    Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Katie M HallahanCole Eye Institute (K.M.H., K.R., A.S.R., W.J.D.), Cleveland Clinic, Cleveland, OH; Storm Eye Institute (K.R.), Medical University of South Carolina, Charleston, SC; Narayana Nethralaya Eye Hospital (A.S.R.), Bengaluru, India; Emory Eye Center (J.B.R.), Atlanta, GA; Stulting Research Center (R.D.S.), Woolfson Eye Institute, Atlanta, GA; and Biomedical Engineering (W.J.D.), Cleveland Clinic Lerner Research Institute, Cleveland, OH.
Karolinne Rocha
Abhijit S Roy
J Bradley Randleman
R Doyle Stulting
William J Dupps

Funding

Corneal Elastography and Patient-Specific Modeling for Simulation-based TherapyR01EY023381 · NEI · CLEVELAND CLINIC LERNER COM-CWRU · PI DUPPS, WILLIAM JOSEPH · 2013 to 2017
$2.0M
NEI NIH HHS R01 EY02338NEI NIH HHS R01 EY023381
6 · The paper itself

Abstract

purposeTo assess changes in Ocular Response Analyzer (ORA) waveforms after UVA/riboflavin corneal collagen cross-linking (CXL) using investigator-derived and manufacturer-supplied morphometric variables in patients with keratoconus (KC) and postrefractive surgery ectasia.

designProspective randomized trial of a standard epithelium-off CXL protocol.

participantsPatients with progressive KC (24 eyes of 21 patients) or postrefractive surgery ectasia (27 eyes of 23 patients) were enrolled.

methodsReplicate ORA measurements were obtained before and 3 months after CXL. Pretreatment and posttreatment waveform variables were analyzed for differences by paired Student t tests using measurements with the highest waveform scores.

main outcome measuresCorneal hysteresis, corneal resistance factor, 37-s generation manufacturer-supplied ORA variables, and 15 investigator-derived ORA variables.

resultsNo variables were significantly different 3 months after CXL in the KC group, and no manufacturer-supplied variables changed significantly in the postrefractive surgery ectasia group. Four custom variables (ApplanationOnsetTime, P1P2avg, Impulse, and Pmax) increased by small but statistically significant margins after CXL in the postrefractive surgery ectasia group.

conclusionsChanges in a small subset of investigator-derived variables suggested an increase in corneal bending resistance after CXL. However, the magnitudes of these changes were low and not commensurate with the degree of clinical improvement or prior computational estimates of corneal stiffening in the same cohort over the same period. Available air-puff-derived measures of the corneal deformation response underestimate the biomechanical changes produced by CXL.

Indexed as

PhotochemotherapyAdultBiomechanical PhenomenaCollagenCorneaCorneal DiseasesCorneal TopographyCross-Linking ReagentsDilatation, PathologicFemaleHumansIntraocular PressureKeratoconusMaleMiddle AgedPhotosensitizing AgentsCollagenCross-Linking ReagentsPhotosensitizing AgentsRiboflavin

Identifiers

PMID25365551
PMCPMC4220297

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.